Also, guanfacine may interact with alcohol or depressant medications - including benzodiazepines, barbiturates, and antipsychotics - leading to an increased sedative effect. Guanfacine can also interact with antihypertensive medications, potentially causing low blood pressure or fainting. Guanfacine can interact with some other medications, including: Guanfacine may not be suitable for children with liver or kidney problems or those with a history of cardiovascular issues, such as low blood pressure or heart disease.ĭoctors may regularly monitor the blood pressure and pulse of some children taking guanfacine to make sure that everything is normal. The manufacturer advises slowly reducing the dosage by 1 mg every 3–7 days. Stopping the medication abruptly can also cause potentially dangerous side effects, including transient hypertension. If a child misses two or more doses, the doctor may suggest restarting at the original 1-mg-per-day dosage and gradually increasing this to reach their regular dosage. Missing doses may cause unpleasant side effects. It is also important to take the pill at the same time every day, such as in the morning or evening, even on weekends and holidays. The child should swallow the tablet whole with a glass of water. The maximum recommended dosage is 4 mg per day.Īs Intuniv is an extended release tablet, it is important never to crush or chew the pill. The manufacturer recommends starting at a dosage of 1 mg per day and increasing this incrementally by no more than 1 mg per week. When prescribing Intuniv, the doctor will typically begin with the lowest dosage and then gradually increase this until the child’s symptoms are under control. The appropriate dosage of Intuniv depends on the child’s age, weight, symptoms, response to the medication, and tolerance of side effects. The extended release form has a slower absorption rate and longer half-life, which means that people do not need to take more than one dose per day and makes it more suitable for children. Intuniv is available as 1-mg, 2-mg, 3-mg, and 4-mg extended release tablets. The FDA has approved Intuniv only for the treatment of ADHD.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |